Status: Bibliographieeintrag
Standort: ---
Exemplare:
---
| |  Online-Ressource |
|---|
| Verfasst von: | Rathmann, Nils-Andreas [VerfasserIn]  |
|---|
| | Sadick, Maliha [VerfasserIn] |
|---|
| | Rathmann, Björn [VerfasserIn] |
|---|
| | Kostrzewa, Michael [VerfasserIn] |
|---|
| | Weiß, Christel [VerfasserIn] |
|---|
| | Schönberg, Stefan [VerfasserIn] |
|---|
| | Diehl, Steffen J. [VerfasserIn] |
|---|
| | Antoni, Christoph Helmer [VerfasserIn] |
|---|
| Titel: | Benefit of patients with an early and progressed state of hepatocellular carcinoma treated with drug-eluting beads |
|---|
| Verf.angabe: | Nils Rathmann, Maliha Sadick, Bjoern Rathmann, Michael Kostrzewa, Christel Weiss, Stefan O. Schoenberg, Steffen J. Diehl and Christoph Antoni |
|---|
| E-Jahr: | 2016 |
|---|
| Jahr: | September-October 2016 |
|---|
| Umfang: | 6 S. |
|---|
| Fussnoten: | Gesehen am 14.01.2019 |
|---|
| Titel Quelle: | Enthalten in: In vivo |
|---|
| Ort Quelle: | Kapandriti, Attiki : IIAR, 2004 |
|---|
| Jahr Quelle: | 2016 |
|---|
| Band/Heft Quelle: | 30(2016), 5, Seite 707-712 |
|---|
| ISSN Quelle: | 1791-7549 |
|---|
| Abstract: | Aim: To evaluate drug-eluting beads (DEB) for transarterial chemoembolization (TACE) in patients with Barcelona Clinic Liver Cancer (BCLC) A to D suffering from hepatocellular carcinoma. Material and Methods: The progression-free interval (PFI), survival and laboratory findings of 46 patients were retrospectively analyzed after DEB TACE. Results: The mean survival interval was 16.93 months. The BCLC A/B group had significantly (p=0.01) longer survival compared to C/D: 20.44 and 10.36 months. Mean PFI was 10.75 months with a significantly (p=0.002) longer PFI of the BCLC A/B group (12.71 months) compared to BCLC C/D (3.91 months). In terms of possible adverse events (AEs) significant changes (p<0.05) were observed in cholinesterase, white blood cells, alkaline phosphatase and C-reactive protein. Conclusion: Mean survival and PFI results in the BCLC A/B patient group were comparable to historical controls. In addition, the results suggest that patients with BCLC stage C/D also benefited from DEB TACE. |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: http://iv.iiarjournals.org/content/30/5/707 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | BCLC |
|---|
| | Hepatocellular carcinoma |
|---|
| | HKLC |
|---|
| | TACE |
|---|
| | tolerance |
|---|
| K10plus-PPN: | 1586194917 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Benefit of patients with an early and progressed state of hepatocellular carcinoma treated with drug-eluting beads / Rathmann, Nils-Andreas [VerfasserIn]; September-October 2016 (Online-Ressource)
68347152
